Orchestra BioMed Holdings, Inc.Orchestra BioMed Holdings, Inc.Orchestra BioMed Holdings, Inc.

Orchestra BioMed Holdings, Inc.

No trades
See on Supercharts

OBIO fundamentals

Orchestra BioMed Holdings, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of OBIO for the last quarter is 778.00 k USD, and it's 25.48% higher compared to the previous quarter. The net income of Q2 24 is -15.98 M USD.

Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: USD
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth